胃癌患者CD163表达与HER-2表达情况的相关性分析
Correlation Analysis of CD163 Expression and HER-2 Expression in Patients with Gastric Cancer
DOI: 10.12677/ACM.2020.1010358, PDF,   
作者: 宋婷婷, 王冰睿, 刘自民*：青岛大学附属医院肿瘤内科，山东 青岛
关键词: 肿瘤相关巨噬细胞；CD163；胃癌；HER-2；预后；Tumor-Associated Macrophages； CD163； Gastric Cancer； HER-2； Prognosis
摘要: 目的：探讨M2型肿瘤相关巨噬细胞特异性受体CD163的表达与HER-2基因及预后的相关性分析。方法：随机选择在2013年1月至2019年12月在青岛大学附属医院接受胃癌手术的60例患者。采用免疫组织化学法检测胃癌组织肿瘤相关巨噬细胞标记物的表达情况，采用χ2检验分析CD163表达与临床病理学参数之间的关系。采用Kaplan-Meier生存分析法分析CD163与预后的关系。结果：CD163+肿瘤相关巨噬细胞与肿瘤生物学行为，即TNM分期(P = 0.017)、淋巴结转移(P = 0.009)呈现明显相关，差别有统计学意义，与HER-2表达水平无显著性差异。CD163+肿瘤相关巨噬细胞与胃腺癌患者术后总生存时间，差别无统计学意义。结论：M2型肿瘤相关巨噬细胞特异性受体CD163的表达与TNM分期、淋巴结转移有关，CD163的表达与HER-2基因之间差异无统计学意义。CD163的表达与胃腺癌患者术后总生存时间差别无统计学意义。
Abstract: Objective: To investigate the correlation analysis between the expression of M2 tumor-associated macrophage specific receptor CD163 and HER-2 gene and prognosis. Methods: Sixty patients who underwent gastric cancer surgery in Qingdao University Hospital from January 2013 to December 2019 were randomly selected. Immunohistochemistry was used to detect the expression of tumor-related macrophage markers in gastric cancer tissues, and the χ2 test was used to analyze the relationship between CD163 expression and clinicopathological parameters. Kaplan-Meier survival analysis method was used to analyze the relationship between CD163 and prognosis. Results: CD163+ tumor-associated macrophages are related to TNM staging (P = 0.017) and lymph node metastasis (P = 0.009), but there is no significant difference in the expression of HER-2. There was no significant difference in overall survival time between CD163+ tumor-associated macrophages and gastric adenocarcinoma patients. Conclusion: The expression of M2 tumor-associated macrophage specific receptor CD163 is related to TNM staging and lymph node metastasis, and there is no significant difference between the expression of CD163 and HER-2 gene. There was no significant difference between the expression of CD163 and the overall survival time of patients with gastric adenocarcinoma.
文章引用：宋婷婷, 王冰睿, 刘自民. 胃癌患者CD163表达与HER-2表达情况的相关性分析[J]. 临床医学进展, 2020, 10(10): 2372-2379. https://doi.org/10.12677/ACM.2020.1010358

参考文献

[1] Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[2] Wyckoff, J.B., Wang, Y., Lin, E.Y., et al. (2007) Direct Visualization of Macrophage-Assisted Tumor Cell Intravasation in Mammary Tumors. Cancer Research, 67, 2649-2656. [Google Scholar] [CrossRef] 
[3] Condeelis, J. and Pollard, J.W. (2006) Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis. Cell, 124, 263-266. [Google Scholar] [CrossRef] [PubMed]
[4] Tauchi, Y., Tanaka, H., Kumamoto, K., et al. (2016) Tumor-Associated Macrophages Induce Capillary Morphogenesis of Lymphatic Endothelial Cells Derived from Human Gastric Cancer. Cancer Science, 107, 1101-1109. [Google Scholar] [CrossRef] [PubMed]
[5] Zhang, W.-J., et al. (2017) High Infiltration of Polarized CD163+ Tumor-Associated Macrophages Correlates with Aberrant Expressions of CSCs Markers, and Predicts Prognosis in Patients with Recurrent Gastric Cancer. Journal of Cancer, 8, 363-370. [Google Scholar] [CrossRef] [PubMed]
[6] Lau, S.K., Chun, P.G. and Weiss, L.M. (2004) CD163: A Specific Marker of Macrophages in Paraffin-Embedded Tissue Samples. American Journal of Clinical Pathology, 122, 794-801. [Google Scholar] [CrossRef] 
[7] Colotta, F., Allavena, P., Sica, A., et al. (2009) Cancer-Related Inflammation, the Seventh Hallmark of Cancer: Links to Genetic Instability. Carcinogenesis, 30, 1073-1081. [Google Scholar] [CrossRef] [PubMed]
[8] Hardbower, D.M., Asim, M., Murray-Stewart, T., et al. (2016) Arginase 2 Deletion Leads to Enhanced M1 Macrophage Activation and Upregulated Polyamine Metabolism in Response to Helicobacter pylori Infection. Amino Acids, 48, 2375-2388. [Google Scholar] [CrossRef] [PubMed]
[9] Gambardella, V., Castillo, J., Tarazona, N., et al. (2020) The Role of Tumor-Associated Macrophages in Gastric Cancer Development and Their Potential as a Therapeutic Target. Cancer Treatment Reviews, 86, Article ID: 102015. [Google Scholar] [CrossRef] [PubMed]
[10] Wang, X.L., Jiang, J.T. and Wu, C.P. (2016) Prognostic Significance of Tumor-Associated Macrophage Infiltration in Gastric Cancer: A Meta-Analysis. Genetics & Molecular Research GMR, 15. [Google Scholar] [CrossRef] [PubMed]
[11] Bang, Y.J., et al. (2010) Trastuzumab in Combination with Chemotherapy versus Chemotherapy Alone for Treatment of HER2-Positive Advanced Gastric or Gastro-Oesophageal Junction Cancer (ToGA): A Phase 3, Open-Label, Randomised Controlled Trial. The Lancet (London, England), 376, 687-697. [Google Scholar] [CrossRef] 
[12] Lindsten, T., Hedbrant, A., Ramberg, A., et al. (2017) Effect of Macrophages on Breast Cancer Cell Proliferation, and on Expression of Hormone Receptors, uPAR and HER-2. International Journal of Oncology, 51, 104-114. [Google Scholar] [CrossRef] [PubMed]
[13] Ruffell, B., Affara, N.I. and Coussens, L.M. (2012) Differential Macrophage Programming in the Tumor Microenvironment. Trends in Immunology, 33, 119-126. [Google Scholar] [CrossRef] [PubMed]
[14] Ries, C.H., Cannarile, M.A., Hoves, S., et al. (2014) Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy. Cancer Cell, 25, 846-859. [Google Scholar] [CrossRef] [PubMed]
[15] Georgoudaki, A.M., Prokopec, K.E., Boura, V.F., et al. (2016) Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis. Cell Reports, 15, 2000-2011. [Google Scholar] [CrossRef] [PubMed]
[16] Go, Y., Tanaka, H., Tokumoto, M., et al. (2016) Tumor-Associated Macrophages Extend along Lymphatic Flow in the Pre-Metastatic Lymph Nodes of Human Gastric Cancer. Annals of Surgical Oncology, 23, S230-S235. [Google Scholar] [CrossRef] [PubMed]
[17] Zhu, Q., Wu, X., Tang, M., et al. (2020) Observation of Tumor-Associated Macrophages Expression in Gastric Cancer and Its Clinical Pathological Relationship. Medicine, 99, e19839. [Google Scholar] [CrossRef] 
[18] Liu, J.Y., Yang, X.J., Geng, X.F., et al. (2016) Prognostic Significance of Tumor-Associated Macrophages Density in Gastric Cancer: A Systemic Review and Meta-Analysis. Minerva Medica, 107, 314.
[19] Zhang, J., Yan, Y., Yang, Y., et al. (2016) High Infiltration of Tumor-Associated Macrophages Influences Poor Prognosis in Human Gastric Cancer Patients, Associates with the Phenomenon of EMT. Medicine, 95, e2636. [Google Scholar] [CrossRef] 
[20] Zhang, H., Wang, X.F., Shen, Z.B., et al. (2015) Infiltration of Diametrically Polarized Macrophages Predicts Overall Survival of Patients with Gastric Cancer after Surgical Resection. Gastric Cancer, 18, 740-750. [Google Scholar] [CrossRef] [PubMed]
[21] Huang, X.P., Pan, Y.M., Ma, J., et al. (2018) Prognostic Significance of the Infiltration of CD163 Macrophages Combined with CD66b Neutrophils in Gastric Cancer. Cancer Medicine, 7, 1731-1741. [Google Scholar] [CrossRef] [PubMed]
[22] Pantano, F., Berti, P., Guida, F., et al. (2012) The Role of Macrophages Polarization in Predicting Prognosis in Radically Resected Gastric Cancer. Annals of Oncology, 23, ix538-ix539. [Google Scholar] [CrossRef] 

为你推荐